The Gross Margin of Seelos Therapeutics Inc (SEEL) is 80.95%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2023-12-31 | 80.95% |
2022-12-31 | 80.95% |
2021-12-31 | 90.09% |